Related references
Note: Only part of the references are listed.Fused-azepinones: Emerging scaffolds of medicinal importance
Ravikumar Akunuri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies
Manasa Kadagathur et al.
BIOORGANIC CHEMISTRY (2020)
Mechanistic and biological characterisation of novelN5-substituted paullones targeting the biosynthesis of trypanothione inLeishmania
Andrea Medeiros et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Organocatalyzed Synthesis and Antibacterial Activity of Novel Quinolino Annulated Analogues of Azepinones
Deepika Arora et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2018)
Alkaloids from the Sponge Stylissa carteri Present Prospective Scaffolds for the Inhibition of Human Immunodeficiency Virus 1 (HIV-1)
Aubrie O'Rourke et al.
MARINE DRUGS (2016)
Novel broad-spectrum inhibitors of bacterial methionine aminopeptidase
Jonathan A. Rose et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Previously Uncultured Marine Bacteria Linked to Novel Alkaloid Production
Eun Ju Choi et al.
CHEMISTRY & BIOLOGY (2015)
Antimicrobial resistance: a global multifaceted phenomenon
Francesca Prestinaci et al.
PATHOGENS AND GLOBAL HEALTH (2015)
Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases
Li Gan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Antifouling activities of hymenialdisine and debromohymenialdisine from the sponge Axinella sp.
Dan Qing Feng et al.
INTERNATIONAL BIODETERIORATION & BIODEGRADATION (2013)
Discovery of a Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905)
Matthew O. Duffey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
EASY-HIT: HIV Full-Replication Technology for Broad Discovery of Multiple Classes of HIV Inhibitors
Stephan Kremb et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Identification of 2-Anilino-9-methoxy-5,7-dihydro-6H-pyrimido[5,4-d][1]benzazepin-6-ones as Dual PLK1/VEGF-R2 Kinase Inhibitor Chemotypes by Structure-Based Lead Generation
Anne-Marie Egert-Schmidt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007
Alicia I. Hidron et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE
Louis B. Rice
JOURNAL OF INFECTIOUS DISEASES (2008)
2-(3-aryl-3-oxopropen-1-yl)-9-tert-butyl-paullones:: A new antileishmanial chemotype
Christina Reichwald et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Inhibition of GSK3 promotes replication and survival of pancreatic beta cells
Rainer Mussmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase:: Chemical library screen and antileishmanial activity
KM Grant et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Inhibition of cytokine production by hymenialdisine derivatives
V Sharma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Paullones are potent inhibitors of glycogen synthase kinase-3β and cyclin-dependent kinase 5/p25
M Leost et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Inhibition of cyclin-dependent kinases, GSK-3 beta and CK1 by hymenialdisine, a marine sponge constituent
L Meijer et al.
CHEMISTRY & BIOLOGY (2000)
Share Paper
